141 related articles for article (PubMed ID: 3263495)
21. Inhibitory effect of calcium antagonists on the depletion of cardiac norepinephrine during postischemic reperfusion.
Nayler WG; Sturrock WJ
J Cardiovasc Pharmacol; 1985; 7(3):581-7. PubMed ID: 2410693
[TBL] [Abstract][Full Text] [Related]
22. [Methoxyflurane and ethanol do not inhibit the neuronal uptake of noradrenaline (uptake 1) at the desipramine binding site].
Kress HG; Schömig E
Anaesthesist; 1990 Jul; 39(7):371-4. PubMed ID: 2386305
[TBL] [Abstract][Full Text] [Related]
23. Ramiprilat attenuates the local release of noradrenaline in the ischemic myocardium.
Carlsson L; Abrahamsson T
Eur J Pharmacol; 1989 Jul; 166(2):157-64. PubMed ID: 2792189
[TBL] [Abstract][Full Text] [Related]
24. Bradykinin promotes ischemic norepinephrine release in guinea pig and human hearts.
Hatta E; Maruyama R; Marshall SJ; Imamura M; Levi R
J Pharmacol Exp Ther; 1999 Mar; 288(3):919-27. PubMed ID: 10027827
[TBL] [Abstract][Full Text] [Related]
25. Effects of lidocaine on catecholamine release in the ischemic rat heart.
Polwin W; McDonald FM; Brinkmann C; Hirche H; Addicks K
J Cardiovasc Pharmacol; 1987 Jan; 9(1):6-11. PubMed ID: 2434796
[TBL] [Abstract][Full Text] [Related]
26. Effect of chronic treatment with tricyclic antidepressants upon antinociception induced by intrathecal injection of morphine and monoamines.
Kellstein DE; Malseed RT; Ossipov MH; Goldstein FJ
Neuropharmacology; 1988 Jan; 27(1):1-14. PubMed ID: 2832778
[TBL] [Abstract][Full Text] [Related]
27. Effects of long-term desipramine administration on noradrenergic neurotransmission: electrophysiological studies in the rat brain.
Lacroix D; Blier P; Curet O; de Montigny C
J Pharmacol Exp Ther; 1991 Jun; 257(3):1081-90. PubMed ID: 1646320
[TBL] [Abstract][Full Text] [Related]
28. Protection of neuronal uptake-1 inhibitors in ischemic and anoxic hearts by norepinephrine-dependent and -independent mechanisms.
Du XJ; Woodcock EA; Little PJ; Esler MD; Dart AM
J Cardiovasc Pharmacol; 1998 Oct; 32(4):621-8. PubMed ID: 9781931
[TBL] [Abstract][Full Text] [Related]
29. Oxaprotiline: induction of central noradrenergic subsensitivity of its (+)-enantiomer.
Mishra R; Gillespie DD; Lovell RA; Robson RD; Sulser F
Life Sci; 1982 May; 30(20):1747-55. PubMed ID: 6285106
[TBL] [Abstract][Full Text] [Related]
30. Release of endogenous catecholamines in the ischemic myocardium of the rat. Part A: Locally mediated release.
Schömig A; Dart AM; Dietz R; Mayer E; Kübler W
Circ Res; 1984 Nov; 55(5):689-701. PubMed ID: 6488489
[TBL] [Abstract][Full Text] [Related]
31. Proarrhythmic effects of pinacidil are partially mediated through enhancement of catecholamine release in isolated perfused guinea-pig hearts.
D'Alonzo AJ; Zhu JL; Darbenzio RB; Dorso CR; Grover GJ
J Mol Cell Cardiol; 1998 Feb; 30(2):415-23. PubMed ID: 9515018
[TBL] [Abstract][Full Text] [Related]
32. The effect of desipramine on basal and naloxone-stimulated cortisol secretion in humans: interaction of two drugs acting on noradrenergic control of adrenocorticotropin secretion.
Torpy DJ; Grice JE; Hockings GI; Crosbie GV; Walters MM; Jackson RV
J Clin Endocrinol Metab; 1995 Mar; 80(3):802-6. PubMed ID: 7883833
[TBL] [Abstract][Full Text] [Related]
33. Either desipramine or TMB-8 suppresses cyanide-induced norepinephrine efflux from in vivo cardiac sympathetic nerves of cats.
Yahagi N; Yamazaki T; Akiyama T
Brain Res; 2000 May; 864(1):157-61. PubMed ID: 10793201
[TBL] [Abstract][Full Text] [Related]
34. Effects of ouabain on in situ cardiac sympathetic nerve endings.
Yamazaki T; Akiyama T; Kawada T
Neurochem Int; 1999 Dec; 35(6):439-45. PubMed ID: 10524711
[TBL] [Abstract][Full Text] [Related]
35. Fasting limits norepinephrine release with myocardial ischemia and reperfusion.
Schaefer S; Wang LF; van der Vliet A; Hristova M; Vulliet PR; Fan SD
Cardiovasc Drugs Ther; 1999 Sep; 13(5):399-405. PubMed ID: 10547219
[TBL] [Abstract][Full Text] [Related]
36. Effects of adrenoceptor antagonists and neuronal uptake inhibitors on dimethylphenylpiperazinium-induced release of catecholamines from the rabbit isolated adrenal gland and guinea-pig atria.
Collett AR; Story DF
J Pharmacol Exp Ther; 1984 Nov; 231(2):379-86. PubMed ID: 6149309
[TBL] [Abstract][Full Text] [Related]
37. Noradrenergic facilitation of shock-probe defensive burying in lateral septum of rats, and modulation by chronic treatment with desipramine.
Bondi CO; Barrera G; Lapiz MD; Bedard T; Mahan A; Morilak DA
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):482-95. PubMed ID: 17188790
[TBL] [Abstract][Full Text] [Related]
38. Clinical studies of the effect of (+) and (-)-oxaprotiline upon noradrenaline uptake.
Checkley SA; Thompson C; Burton S; Franey C; Arendt J
Psychopharmacology (Berl); 1985; 87(1):116-8. PubMed ID: 3933029
[TBL] [Abstract][Full Text] [Related]
39. Effect of acute and chronic treatment of tandamine, a new heterocyclic antidepressant, on biogenic amine metabolism and related activities.
Pugsley TA; Lippmann W
Naunyn Schmiedebergs Arch Pharmacol; 1979 Sep; 308(3):239-47. PubMed ID: 503251
[TBL] [Abstract][Full Text] [Related]
40. Effects of antidepressants on the uptake and release of norepinephrine from rat cerebral cortex.
Rubinstein-Kawamoto J; Davis JM; Pandey GN
Psychopharmacology (Berl); 1984; 84(2):155-7. PubMed ID: 6438673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
